Market Research Logo

BioDiem Ltd - Strategic SWOT Analysis Review

BioDiem Ltd - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company’s product portfolio includes Live Attenuated Influenza Virus (LAIV) vaccine technology, used for production of seasonal and pandemic influenza vaccines and antimicrobial BDM-I for the treatment of serious human infections. BioDiem partners with other vaccine and infectious disease treatment companies through licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organisation as part of the Global Pandemic Influenza Action Plan. BioDiem is headquartered in South Melbourne, Victoria, Australia.

BioDiem Ltd Key Recent Developments

Mar 17,2017: BioDiem Announces its Half Year Results

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
BioDiem Ltd - Key Facts
BioDiem Ltd - Key Employees
BioDiem Ltd - Key Employee Biographies
BioDiem Ltd - Major Products and Services
BioDiem Ltd - History
BioDiem Ltd - Company Statement
BioDiem Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioDiem Ltd - Business Description
BioDiem Ltd - Corporate Strategy
BioDiem Ltd - SWOT Analysis
SWOT Analysis - Overview
BioDiem Ltd - Strengths
BioDiem Ltd - Weaknesses
BioDiem Ltd - Opportunities
BioDiem Ltd - Threats
BioDiem Ltd - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
BioDiem Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 17, 2017: BioDiem Announces its Half Year Results
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
BioDiem Ltd, Key Facts
BioDiem Ltd, Key Employees
BioDiem Ltd, Key Employee Biographies
BioDiem Ltd, Major Products and Services
BioDiem Ltd, History
BioDiem Ltd, Subsidiaries
BioDiem Ltd, Key Competitors
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
BioDiem Ltd, Recent Deals Summary
List of Figures
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report